Search for: "Pharmaceutical Generic Developers, Inc."
Results 121 - 140
of 1,119
Sorted by Relevance
|
Sort by Date
22 Mar 2012, 1:15 pm
New Case Report About Routine Fall Involving An Elderly Patient That Results In Fatal Irreversible Brain Hemorrhage (Posted by Tom Lamb at DrugInjuryWatch.com) Pradaxa® is the name under which Boehringer Ingelheim Pharmaceuticals, Inc. markets a prescription anticoagulant medication generically called dabigatran. [read post]
2 Apr 2011, 11:58 pm
Sanofi-Aventis sued Sun Pharmaceutical for its generic mimic of a cancer treatment drug, oxaliplatin. [read post]
19 Nov 2015, 10:08 am
Janssen Pharmaceuticals Inc., et al., (County of Philadelphia). [read post]
9 Aug 2011, 8:24 pm
In the Order, ALJ Rogers granted-in-part and denied-in-part non-parties Teva Pharmaceuticals USA, Inc. and Teva Parenteral Medicines, Inc. [read post]
30 Aug 2021, 8:11 am
Takeda Pharmaceutical Co Ltd lost its bid at the 2nd U.S. [read post]
3 Apr 2009, 5:10 am
Developing green technologies. [read post]
26 Sep 2010, 9:28 am
©2010 Amaxx Risk Solutions, Inc. [read post]
3 Jun 2015, 9:55 am
Actavis, Inc., 133 S. [read post]
26 Sep 2009, 3:00 am
The immunology company is developing a new generation of vaccines for the prevention of infectious diseases. [read post]
29 Dec 2009, 9:09 pm
Miller, Vice President of Corporate Business Development, Eli Lilly Reid Leonard, Vice President External Licensing and Business Development, Merck Jules Musling, VP, Johnson & Johnson Carlos Garrido, Finance Director , Head of Strategic Planning and Business Development South America, AstraZeneca Peter Verheyen, VP Business Development, Johnson & Johnson Michael Lytton, EVP Business Development, Biogen Idec Inc Mark Dennish, Vice… [read post]
30 Sep 2019, 6:08 am
Here are some of the developments in antitrust news this past week that we found interesting and are following. [read post]
22 Jan 2007, 7:41 am
In Ortho-McNeil Pharmaceutical, Inc. v. [read post]
17 Oct 2017, 6:09 pm
Judge Robinson had concluded that the patent was valid, and applied the test articulated in eBay Inc. v. [read post]
4 Nov 2013, 3:04 am
On November 4, the Department of Justice announced that Johnson & Johnson and its subsidiaries, Janssen Pharmaceuticals, Inc., and Scios, Inc., had agreed to pay $2.2 billion to resolve claims originally brought by whistleblowers that the company promoted its drugs Risperdal, Invega, and Natrecor for unapproved (off-label) uses. [read post]
15 Feb 2011, 4:06 am
Moreover, the industry has agreed upon and abides by the PhRMA Code to regulate the marketing of medicine to healthcare professionals-just as any consumer-products maker might develop rules to limit the express warranties its sales force might offer to a customer. [read post]
6 May 2024, 8:26 am
We don’t want to impugn good patents or heap undue costs on firms that develop useful pharmaceuticals. [read post]
3 Feb 2020, 6:14 am
The Federal Trade Commission and the office of the New York attorney general, Letitia James, jointly sued Vyera Pharmaceuticals and the company’s owners, Mr. [read post]
2 Oct 2010, 8:43 am
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
15 Feb 2012, 7:42 am
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:08 pm
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
